[OP.LB.02.04] CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS FOR UNCONTROLLED HYPERTENSION: 12 MONTH FOLLOW UP RESULTS OF THE ROX CONTROL HTN RANDOMISED CONTROLLED TRIAL

M. Lobo,M. Saxena,P. Sobotka,C. Ott,E. Dolan,J. Foran,S. Furniss,J. Cockcroft,M. van der Giet,J. Hoyer,A. Januszewicz,G. Ng,B. Rensing,B. Scott,D. Schoors

DOI: https://doi.org/10.1097/01.hjh.0000491540.41256.05

IF: 4.9

2016-09-01

Journal of Hypertension

Abstract:Objective: Creation of a central iliac arteriovenous (AV) anastomosis using a novel nitinol coupler device results in an immediate, significant reduction of blood pressure (BP). We present efficacy and safety findings at 12 months post coupler insertion, extending the initial 6 month primary endpoint report (Lancet 2015). Design and method: This open-label, multicentre, prospective, randomised trial, enrolled patients with a baseline office systolic blood pressure (SBP) >140 mmHg, average daytime ambulatory SBP > 135 mmHg, and ambulatory diastolic blood pressure (DBP) > 85 mmHg. Subjects were randomly allocated to AV coupler implantation and continuing previous pharmacotherapy, or to maintain previous treatment alone. Results: Eighty-three (43%) of 195 patients screened for eligibility were randomly allocated to AV coupler therapy (n = 44) or control (n = 39) groups. At 12 months, 39 patients who had AV coupler therapy were included in the intention to treat analysis. Office-based SBP reduced by 25.1 ± 23.3 mmHg (baseline 175 ± 18 mmHg, p < 0·0001) post AV coupler placement, and office DBP reduced by 20.8 ± 13.3 mmHg (baseline 100 ± 13 mmHg, p < 0·0001). Mean 24-hour ambulatory SBP reduced by 12.6 ± 17.4 mmHg (baseline 157 ± 15 mmHg, p < 0·0001), post coupler treatment. Mean 24-hour ambulatory DBP reduced by 15.3 ± 9.7 mmHg (baseline 93 ± 11 mmHg, p < 0·0001). (see Figure). Figure. No caption available. In a pre-specified subset of patients who had failed to respond adequately to prior renal denervation, AV coupler therapy lead to highly significant reduction in office SBP/DBP (30.7/24.1 mmHg) and significant reduction in 24 hour ambulatory SBP/DBP (12.4/14.4 mmHg) at 12 months follow up. In the 12 months following randomisation, the control population has experienced a single death, attributed to hypertensive heart failure, and 6 hospitalisations in 4 patients. Following AV coupler therapy, 14 patients (33%) developed ipsilateral venous stenosis; all were treated successfully with venous stenting. Conclusions: Office and ambulatory BP were substantially and durably reduced following coupler implantation. The control population experienced both hypertension-related morbidity and mortality, not observed in the treatment group. These findings confirm the importance of arterial mechanics in the pathophysiology of hypertension and support the clinical utility of a central iliac AV anastomosis.